This work mainly aimed to investigate the probable changes of aortic calcification by policosanol, omega-3 fatty acids in comparison with atorvastatin and subsequent progression of atherosclerosis in diabetic hyperlipemic rat model. Adult male albino rats of wistar strain (30) were divided into five groups (n ¼ 6/group); one was fed normal diet and was used as a normal group, the other groups received alloxan, atherogenic diet (CCT -rat chow diet supplemented with 4% cholesterol, 1% cholic acid, and 0.5% thiouracil) and categorized as follows: the second group received no treatment and kept as control (diabetic hyperlipidemic control group (DHC)). The other groups received daily oral doses of atorvastatin, policosanol (10 mg/kg body weight) and o-3 (50 mg/kg body weight), respectively, for eight weeks. Different biomarkers were used for the evaluation that included inflammatory (C reactive protein (CRP), tumor necrosis factor a (TNF-a)), oxidative stress (glutathione (GSH), malondialdehyde (MDA)) bone calcification markers (alkaline phosphatase (ALP), Vitamin D, parathyroid hormone (PTH)), lipogram pattern in addition to histochemical demonstration of calcium in the aorta. Diabetic hyperlipemic group demonstrated significant hyperglycemia, hyperlipidemia, and increased inflammation, oxidative stress, calcification, and finally atherogenesis progression. Treatment of diabetic hyperlipemic rats with, policosanol, omega-3 fatty acids (natural products) and atorvastatin for eight weeks significantly increased high-density lipoprotein cholesterol (HDL-C), Vitamin D, decreased aortic vacuoles number, and inhibited calcification process. Policosanol induced more remarkable reduction in the density and number of foam cells and improved the intimal lesions of the aorta as compared to atorvastatin. Drugs under study exerted hypoglycemic effect along with an inhibition of inflammation, oxidative stress, and calcium deposition with certain variations but policosanol effect was remarkable in comparison with other drugs.
Introduction
It has been reported that inflammatory factors, such as cytokines and modified lipoproteins, play a significant role in atherosclerotic calcification, and many clinical studies attributed these factors to the progression of vascular calcification as indicated by the hyperlipidemia score. 1 Oxidative stress, the subsequent free radical formation, and changes in serum Ca þþ and phosphorus (P) levels can activate vascular smooth muscle cells (VSMCs) differentiation in the vascular wall. This may collectively lead to the loss of many calcification inhibitors, such as matrix Glaprotein, osteopontin, and Fetuin-A. 2 A reported study, which used hyperlipidemic mice, has demonstrated that the promotion of calcification and cholesterol played a certain role in the precipitation of calcium crystals. 3 Modified lipoproteins in a hyperlipidemic state can also induce calcification and osteogenic differentiation in vascular cells. 4 The reverse was shown to be true in the osteoblasts of skeletal bones, a finding which may support the lipid hypothesis of osteoporosis. 4 In addition to expressing osteopontin, bone morphogenetic protein (BMP-2) is also present in human atherosclerotic plaques. 5 An in vitro study, which used calcifying vascular cells incubated with graded levels of TNF-a, showed a gradual increase in alkaline phosphatase and calcium deposition. 6 This result indicates the important role of TNF-a considering that alkaline phosphatase is mainly derived from osteoblast cells. 6 The link between atherosclerotic mineralization and inflammation has been recorded. 7 Moreover, generation of reactive oxygen species (ROS) in atherosclerotic lesions and its role in vascular calcification has also been discussed. 8 Statin drugs have been suggested for the treatment of vascular calcification. 9 TNF-a, as an inducer of vascular calcification, showed significant inhibition in a dose-dependent manner under the influence of cerivastatin and atorvastatin. 10 Similarly, inhibition of ALP expression was also observed. 10 The hypolipidemic effects of policosanol (PC) were reported in experimental animals that received PC, demonstrating its efficacy as a natural antioxidant and a potential inhibitor of platelet aggregation, endothelial damage, and foam cell formation. 11 Statins have the same mechanism as 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMG-CoA reductase), a reductase inhibitor and activator of low-density lipoprotein (LDL) receptor processing. 12 Clinical studies conducted on healthy volunteers, 13 hypercholesterolemic individuals, 14 and diabetics with dyslipidemia 15 have confirmed the efficacy and safety of statins and PC.
The present study was undertaken to investigate the effects of PC and omega-3 fatty acids (o-3) (natural products) on hyperlipidemia, oxidative stress, inflammatory degree, and aortic calcification patterns in a diabetic hyperlipidemic rat model and to compare these effects to the effects of the hypolipidemic drug atorvastatin (synthetic product).
Laboratory animals
Male albino rats (Wistar strain), weighing 150 AE 10 g (10 to 12 weeks old) were used. Rats had free access to water and a standard chow diet throughout the experimental period. The experimental design and animal handling were approved by the Ethical committee of the faculty of pharmacy at Zagazig University (NO p23/12/2014).
Experimental procedure
After one week of acclimation, rats were randomly assigned to five groups (six rats/group). The first group, referred to as the normal group (NG), received the standard chew diet. The other four groups received freshly prepared alloxan (125 mg/kg) dissolved in saline and delivered subcutaneously. 16, 17 Six hours later, the drinking water was supplemented with 10% glucose for 24 h to avoid hypoglycemic shock. 18 A blood sample was collected from each rat to test for blood glucose levels. Rats with a serum glucose level ! 150 mg/dl were considered diabetic and fed the CCT diet (normal chow diet supplemented with 4% cholesterol, 1% cholic acid and 0.5% thiouracil in the drinking water) for two weeks. 19 Three groups of rats received atorvastatin (10 mg/kg), PC (10 mg/kg), or o-3 fatty acids (50 mg/kg) for eight weeks along with the CCT diet. Rats in the fourth group received no treatment (only CCT diet) and were treated as a control group.
Because these drugs are insoluble in water, fresh suspensions were prepared using gum acacia as a suspending agent prior to the oral intake.
At the end of the experiment, blood was withdrawn from fasted rats for serum preparation. The serum glucose and lipid profile were tested immediately. The remaining serum was stored at À20 C to determine the levels of CRP, TNF-a, Vitamin D, PTH, ALP, MDH, and GSH.
After the rats were sacrificed, the whole aorta from each rat was removed, rinsed with cold normal saline, dried with filter paper, and kept in 10% formalin-saline at 4 C for at least one week (primary fixation). Then, the specimens were dehydrated with a series of ascending grade ethanol from 75% to 100% and immediately processed by the paraffin technique. Sections of 5 mm thickness were cut, processed on slides, and stained with hematoxylin and eosin 20 for histological microscopic analyses. Another part of the aorta was stained with alizarin red S for the histochemical demonstration of calcium deposition in the aorta. 21 The sections were deparaffinized and hydrated with 70% alcohol, rinsed rapidly with distilled water and immersed in Alizarin red S solution for 5 min. The excess dye was removed, and the sections were treated with 20 drops of acetone followed by 20 drops of acetone-xylene and were then cleared in xylene. Calcium forms an alizarin red S-calcium complex through a chelation process and appears as orange-red deposits.
Chemical agents
Alloxan monohydrate (98%) was purchased from Acros-Organics Chemical Co. (USA). Cholesterol and cholic acid were purchased from Alpha Chemical Co. (India). 2-Thiouracil was purchased from Riedel-De Haen Ag Seelze-Hannover (Germany). Atorvastatin was kindly supplied by the Medical Union of Pharmaceuticals (MUP, Egypt). Fish oil (o-3) fatty acids were purchased from Arab Co. for Gelatin and Pharmaceutical Products (Egypt). The alizarin red stain was supplied by the Oxford Lab, Mumbai, India.
Laboratory analysis
TC and HDL-c levels were determined colorimetrically using kits supplied by Spinreact Co., Spain. TAG levels were determined colorimetrically using the kit provided by Biomed Co., Egypt. LDL-C levels were calculated using the Friedewald formula. CRP levels were determined by a rat ELISA kit supplied by BD Biosciences Co., Germany.
TNF-a levels were determined by a rat immunoassay kit provided by R&D Systems, USA. MDA and GSH levels were determined by kits supplied by BioDiagnostics Co., Egypt. Alp levels were determined by a kit supplied by Vitro Medical Co., Germany. Vitamin D was determined by an ELISA kit supplied by Bio Vendor Research Co., Germany. PTH levels were determined by a rat ELISA kit provided by Cusabio Biotech Co., China.
Isolation and characterization of PC
Sugarcane peels were collected from a local juice center in Egypt. The wax was extracted from the peels, and additional purification and characterization of PC were carried out as previously described. 22, 23 
Statistical analysis
Data values were expressed as M AE SD. Differences between groups were assessed using one-way analysis of variance. Tukey-Kramer test was performed for inter-group comparisons (GraphPad). Pearson's correlation coefficient was used to determine correlations.
Significant results at p values 0.001, 0.01, and 0.05 are represented with symbols in the tables and figures.
Results

Effects of the treatments on serum glucose and oxidative stress markers
For rats treated with alloxan, a significant increase (p < 0.001) in the serum glucose level was observed compared to the NG rats. Treatment of DHC rats with PC, o-3 fatty acids, and atorvastatin for eight weeks induced a remarkable decrease in the serum glucose levels (Figure 1 ). Oxidative stress, expressed as MDA, significantly increased along with the GSH reduction in the DHC group compared to the NG group (p < 0.001). Additionally, PC treatment increased GSH (p < 0.001). PC and o-3 attenuated the serum MDA content (p < 0.001, p < 0.05) compared to the DHC group. ATOR treatment induced similar effects ( Table 1) .
Effects of PC, u-3 fatty acids, and ATOR on serum lipoproteins
The DHC group demonstrated a significant increase (p < 0.001) of serum TC, LDL-C, and TAG along with a decrease of HDL-C compared to NG group. Treatment of diabetic hyperlipemic (DH) rats with both PC and o-3 fatty acids for eight weeks induced a significant decrease in serum levels of total LDL-C and TAG along with an increase of HDL-C (p < 0.001). PC showed more pronounced effects on these factors compared to the ATOR group. PC, o-3, and ATOR significantly increased HDL-C (p < 0.001) and decreased LDL-C (p < 0.001, p < 0.05) compared to the DH rats ( Table 1) .
Effects of PC, u-3 fatty acids, and ATOR on serum inflammatory markers
TNF-a and CRP were significantly increased in DH rats compared to the NG rats (p < 0.001). PC, o-3, and ATOR individually induced a significant decrease in the serum TNF-a and CRP levels (p < 0.001; Table 2 ).
Effects of PC, u-3 fatty acids, and ATOR on serum PTH, ALP, and Vitamin D levels
Treatment with PC, o-3 fatty acids, and ATOR for eight weeks caused a significant increase in PTH and ALP serum levels (p < 0.001) and a decrease in Vitamin D serum levels in DH rats, compared to the NG rats (p < 0.001). PC and o-3 treatments for eight weeks resulted in decreased PTH and ALP levels (p < 0.001) and increased Vitamin D levels(p < 0.001). These effects were more remarkable than those that were observed after ATOR treatment ( Table 2) .
Histopathological results
Hematoxylin and eosin staining of the aorta of normal rats illustrated irregular tunica intimae (TI), tunica media (TM) with elastic fibers and tunica adventitia (TA) with red blood cells in the lumen (Figure 2a and 2b) . The aorta of DHC rats demonstrated a separation of the endothelial cells, denoting an intimal injury. Neointimal lesions showed more foam cells (Figure 2c ). The aorta of ATOR-treated rats showed a reduction in the density and the number of foam cells, reflecting an improvement of the intimal lesions (Figure 2d ). The aorta of o-3-treated rats exhibited a greater reduction in the density and number of foam cells (Figure 2f ). The aorta of PCtreated rats showed a marked improvement of the intimal lesions, approaching the normal pattern (Figure 2e ).
Discussion
The observed decrease in total cholesterol is mainly attributed to an inhibition of HMG-CoA reductase activity and to the induction of AMP kinase phosphorylation. The latter may lead to further inhibition of HMG-CoA reductase activity 24 and the inactivation of acetyl CoA carboxylase, 25 leading to an inhibition of fatty acid biosynthesis. 26 Several studies have discussed that hypercholesterolemic rabbits, following the oral administration of PC (50 mg/kg) for 30 days, demonstrated a significant decrease of hepatic sterol content and an improvement in LDL-C clearance. 27 Similar findings were also observed during the incubation of human lung fibroblasts with PC for 48 h, 28 where the incorporation of H3 water and C14 uptake (C14-acetate) showed a significant decrease.
Clinical studies have been conducted using different patient categories, e.g. Type 11 hypercholesterolemic, hypertensive, and T2 DM, and daily administration of 5-20 mg PC resulted in a significant reduction in LDL-c levels. 29 These findings may collectively support the PC mechanism as an effective hypolipidemic agent.
Marked side effects, such as hepatotoxicity and myopathy, 30 have been observed following the long-term use of various hypolipidemic drugs, such as statins, nicotinic acid fibrates, and ion-exchange resin.
The opposite was true during PC intake (10 mg/day) compared to Lovastatin intake (20 mg/day) for 12 weeks All data are presented as the mean AE SD, n ¼ 6. where PC demonstrated safety, tolerability, and marked improvement in the HDL-C level. 15 The clinical use of PC in combination with o-3 fatty acids for hypercholesterolemic patients also demonstrated marked improvements in their lipid profiles. 31 The present study has shown the antioxidant properties of PC represented by a significant increase in GSH and a decrease in MDA.
Previous studies indicated that PC administration in a dose range between 100 and 250 mg/kg daily for four weeks resulted in a partial prevention of rat microsomal lipid peroxidation. 32 An in vitro study using copper-induced lipoprotein peroxidation has reported similar results. 32 Inflammatory markers, such as TNF-a and CRP, also showed a significant decrease, which was more remarkable after PC treatment compared to treatment with atorvastatin and o-3 fatty acids (Figure 3 ).
This decrease may reflect its anti-inflammatory property, which is in agreement with the previous reports. 11 First, TNF-a can increase ALP and calcium deposition in the calcifying vascular cells, 6 and second, it can regulate the osteogenic signal that is involved in aortic calcification. 33 Specific atherosclerotic factors, such as Lpa, can also exert an important role in vascular calcification. 34 Rabbit aortic smooth muscle cells incubated with Lpa in vivo showed significantly increased ALP and calcium accumulation. 34 Endothelial dysfunction has previously been attributed in several studies to increased BMP expression, calcification, oxidative stress, and hypoxia. 35, 36 VSMCs incubation with either TNF-a or ox LDL also significantly increased BMP-2 expression, 37 taking into consideration that inflammation and inflammatory cytokine formation, such as TNF-a, are mostly attributed to oxidative stress. 38 There are two types of major calcium modulators that regulate hormones, and their receptors are known, namely PTH, Vitamin D, 39 serum calcium (ionized), and the calcium-sensing receptor. 40 The present study recorded a significant decrease in Vitamin D and an increase in the PTH levels of DHC rats. The administration of drugs under this study induced the opposite effect compared to the control group, and PC exerted remarkable effects (Figure 3 ).
For this reason, the PTH determination in this study may be beneficial for monitoring calcium disturbance in individuals suffering from kidney disease. 41 Increased PTH activity may also lead to excessive H 2 O 2 liberation from mononuclear cells and an intracellular increase of calcium. 42 This may collectively lead to disturbed ATP output due to impairments of mitochondrial function, oxidative stress, ROS formation, inflammation and necrosis of cardiac tissues. 42 The hypoglycemic effect of PC has mainly been attributed to an AMP-kinase activation that was similar to a metformin mechanism, which led to the activation of glucose uptake into the skeletal muscle, inhibition of hepatic gluconeogenesis, and finally decreased circulating lipids. 43, 44 Conclusions PC administration to diabetic hypercholesterolemic rats demonstrated hypolipemic, hypoglycemic, anti-oxidant, and anti-inflammatory effects along with remarkable inhibition of vascular calcification (Figure 4 ). Histopathological examination of the aorta revealed an improvement of intimal lesion as compared to o-3 fatty acids and atorvastatin.
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